09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

2-AMINOANTHRAQUINONE<br />

CAS No: 117-79-3<br />

I. PHYSICAL AND CHEMICAL PROPERTIES (From HSDB (1994) except where<br />

noted)<br />

Molecular weight 223.24<br />

Boiling point sublimes (IARC, 1982)<br />

Melting point 302 °C<br />

Vapor pressure<br />

not available<br />

Air concentration conversion 1 ppm = 9.131 mg/m 3<br />

II.<br />

HEALTH ASSESSMENT VALUES<br />

Unit Risk Factor: 9.4 E-6 (µg/m 3 ) -1<br />

Slope Factor: 3.3 E-2 (mg/kg-day) -1<br />

[Male rat liver tumor data (NCI, 1978), contained in Gold et al. database (1984), expedited<br />

Proposition 65 methodology (Cal/EPA, 1992), cross-route extrapolation.]<br />

III.<br />

CARCINOGENIC EFFECTS<br />

Human Studies<br />

No studies on the potential carcinogenic effects of 2-aminoanthraquinone (2-AA) on humans are known<br />

to exist.<br />

Animal Studies<br />

Results from the National Cancer Institute (NCI) (1978) feeding study in male and female B6C3F 1<br />

mice and Fischer 344 rats are tabulated in Gold et al. (1984). 2-Aminoanthraquinone (technical grade,<br />

unspecified impurities) was administered in feed to groups of 50 male and 50 female animals of each<br />

species. Matched control groups were included for each mouse dose group (50 animals/sex/species).<br />

Control groups of 50 male and 25 female rats were also included; these animals were observed for<br />

107-109 weeks. Diet fed to mice contained 5000 or 10000 mg/kg 2-AA; diet fed to female rats<br />

contained 2000 mg/kg 2-AA. Diet fed to male rats contained 10000 or 20000 mg/kg 2-AA for the<br />

first 10 weeks; this was reduced to 2500 or 5000 mg/kg for the remaining 68 weeks. For rats, NCI<br />

reported the time-weighted average dietary concentrations to be 0.69% and 0.35% for high and low<br />

dose males, and 0.2% for treated females over a 78-week period. An additional observation period of<br />

28-32 weeks was included after treatment ended. High and low dose mice of both sexes were<br />

administered time-weighted average dietary concentrations of 1.0% (over 80 weeks) and 0.5% (over<br />

78 weeks) respectively, and were observed for an additional 15-16 weeks after treatment ended.<br />

At study termination, 82, 78, 94 and 86% of male mice and 78, 76, 88 and 76% of female mice were<br />

55

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!